Hansoh Pharmaceutical Group
$34.02Change from previous close: −3.63%Absolute change: −$1.28
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 15,028 | 12,261 | 10,104 | 9,382 |
| Cost of revenue | 1,498 | 1,105 | 1,031 | 867 |
| Gross profit | 13,530 | 11,155 | 9,073 | 8,515 |
| Selling, general and administrative | 4,736 | 4,508 | 4,241 | 4,148 |
| Research and development | 3,358 | 2,702 | 2,097 | 1,693 |
| Operating income | 5,547 | 4,031 | 2,839 | 2,791 |
| EBIT | 6,554 | 5,092 | 3,833 | 3,007 |
| EBITDA | 6,947 | 5,493 | 4,199 | 3,351 |
| Interest expense | 3.2 | 6.7 | 66.7 | 58.1 |
| Pre-tax income | 6,551 | 5,085 | 3,766 | 2,948 |
| Income tax | 995 | 713 | 489 | 365 |
| Net income | 5,555 | 4,372 | 3,278 | 2,584 |
| Net income to common shareholders | 5,555 | 4,372 | 3,278 | 2,584 |
| Basic EPS | 0.93 | 0.74 | 0.55 | 0.44 |
| Diluted EPS | 0.93 | 0.73 | 0.52 | 0.44 |
| Average shares (basic) | 5,963 | 5,930 | 5,925 | 5,916 |
| Average shares (diluted) | 5,981 | 5,950 | 6,020 | 5,929 |